Skip to main content
. 2024 Nov 25;26:161. doi: 10.1186/s13058-024-01923-5

Table 1.

Overview of PCOS and BC included in this study

Diseases Abbreviations PMID Data source Year Population N Cases Controls Reference genome
breast cancer BC 32,424,353 https://bcac.ccge.medschl.cam.ac.uk/bcacdata/oncoarray/oncoarray-and-combined-summary-result/ 2020 European 247,173 133,384 113,789 GRCh39 (hg19)
ER + breast cancer ERPBC 29,059,683 ieu-a-1127 2017 European 175,475 69,501 105,974 GRCh39 (hg19)
ER- breast cancer ERNBC 29,059,683 ieu-a-1128 2017 European 127,442 21,468 105,974 GRCh39 (hg19)
polycystic ovarian syndrome PCOS 30,566,500 https://www.repository.cam.ac.uk/handle/1810/289950 2018 European 113,238 10,074 103,164 GRCh39 (hg19)

Overview of PCOS and BC, abbreviations as used throughout the manuscript, associated PubMed ID, Data source and Year of publication, the sample size, population and reference genome on which summary statistics are based, and the number of SNPs included in the original summary statistics, before we applied filtering